CJC-1295 + GHRP-2 10 mg Blend

Growth hormone axis Research compound (not approved for human use)

Growth-hormone axis blend · also known as CJC/GHRP-2

For reference only — not medical advice. Figures are commonly reported values compiled from published sources and may be wrong or out of date. Many compounds listed are not approved for human use. Talk to a licensed clinician before using any compound.

This 10 mg vial pairs CJC-1295 with GHRP-2. Human physiology work shows that combining a GHRH-type signal with a growth-hormone-releasing peptide produces a larger GH response than either alone, though that work used controlled intravenous administration rather than this exact blend.

Commonly reported dosing (10 mg vial)

Reconstituted with 3 mL → 3.333 mg/mL.

Phase	Dose	Volume	U-100 units
Starting Weeks 1-2, total blend	150 mcg	0.045 mL	4.5
Standard Weeks 3-12, total blend	300 mcg	0.09 mL	9

Each 150 mcg draw contains 75 mcg CJC-1295 (With DAC) + 75 mcg GHRP-2.

Frequency: Once daily, commonly in the evening on an empty stomach (some protocols split it into two daily doses), subcutaneous · Half-life: Mixed (CJC-1295 DAC long; GHRP-2 about 30 minutes)

Open in calculator

Commonly reported reconstitution steps

Vials are usually brought to room temperature (about 15-20 minutes) first.
3 mL of bacteriostatic water is added slowly down the inside wall of the 10 mg vial.
The vial is swirled gently until clear, not shaken.
This gives 3.33 mg/mL. Mixed vials are typically labeled with the date and refrigerated.

Storage

Before mixing: Sealed vials are commonly stored refrigerated (2-8 °C) and protected from light, or frozen for long-term storage.

After mixing: Reconstituted solution is commonly kept refrigerated (2-8 °C), protected from light, and not frozen.

Commonly used within 28 days of mixing.

How it works

CJC-1295 is a GHRH analog whose long-acting form binds albumin to extend its duration, while GHRP-2 acts on the ghrelin/GHS receptor to trigger a quick GH pulse. The pairing is studied as a sustained-plus-pulsatile stimulus.

Researched for

Studied for synergistic GH release when GHRH and GHRP signals are combined.
Investigated in short-cycle growth-hormone axis research.

Notes

The reference page does not state which CJC-1295 form or what component split is used. The DAC form (it cites the long-acting GH/IGF-1 data and links its DAC article) and an even 5 mg / 5 mg split are assumed here; treat the split as unverified.
GHRP-2 can raise appetite, cortisol and prolactin in some studies.
GH responses to this class are reported to be blunted when blood glucose is elevated, so fasting is a common research variable.
Reconstituted solution is commonly refrigerated.